TNF and systemic lupus erythematosus: Etanercept (Enbrel), a soluble TNF p75 receptor that acts as a TNF-α antagonist by inhibiting TNF-α interaction with its cell surface receptor, significantly decreased systemic inflammation and bone loss in the FcγRIIb-/- lupus model.